Previous Article | Next Article ![]()
Journal of Bacteriology, August 2000, p. 4304-4309, Vol. 182, No. 15
Department of Bacteriology, University of
Wisconsin-Madison, Madison, Wisconsin
Received 30 November 1999/Accepted 15 May 2000
Reduction of the cobalt ion of cobalamin from the Co(III) to the
Co(I) oxidation state is essential for the synthesis of
adenosylcobalamin, the coenzymic form of this cofactor. A cob(II)alamin
reductase activity in Salmonella enterica serovar
Typhimurium LT2 was isolated to homogeneity. N-terminal analysis of the
homogeneous protein identified NAD(P)H:flavin oxidoreductase (Fre) (EC
1.6.8.1) as the enzyme responsible for this activity. The
fre gene was cloned, and the overexpressed protein, with a
histidine tag at its N terminus, was purified to homogeneity by nickel
affinity chromatography. His-tagged Fre reduced flavins (flavin
mononucleotide [FMN] and flavin adenine dinucleotide [FAD]) and
cob(III)alamin to cob(II)alamin very efficiently. Photochemically
reduced FMN substituted for Fre in the reduction of cob(III)alamin to
cob(II)alamin, indicating that the observed cobalamin reduction
activity was not Fre dependent but FMNH2 dependent.
Enzyme-independent reduction of cob(III)alamin to cob(II)alamin by
FMNH2 occurred at a rate too fast to be measured. The
thermodynamically unfavorable reduction of cob(II)alamin to
cob(I)alamin was detectable by alkylation of the cob(I)alamin
nucleophile with iodoacetate. Detection of the product,
caboxymethylcob(III)alamin, depended on the presence of
FMNH2 in the reaction mixture. FMNH2 failed to
substitute for potassium borohydride in in vitro assays for corrinoid
adenosylation catalyzed by the ATP:co(I)rrinoid adenosyltransferase
(CobA) enzyme, even under conditions where Fre and NADH were present in
the reaction mixture to ensure that FMN was always reduced. These
results were interpreted to mean that Fre was not responsible for the
generation of cob(I)alamin in vivo. Consistent with this idea, a
fre mutant displayed wild-type cobalamin biosynthetic
phenotypes. It is proposed that S. enterica serovar
Typhimurium LT2 may not have a cob(III)alamin reductase enzyme and
that, in vivo, nonadenosylated cobalamin and other corrinoids are
maintained as co(II)rrinoids by reduced flavin nucleotides generated by
Fre and other flavin oxidoreductases.
The biologically active, coenzymic
form of cobalamin (Cbl) contains a 5'-deoxyadenosyl (Ado) group as the
upper axial ligand (Fig. 1). Formation of
the C-Co bond between the cobalt ion and the upper ligand requires that
the cobalt ion be reduced to its +1 oxidation state. Reduction of
Co(III) to Co(I) is thought to proceed in two consecutive one-electron
reductions catalyzed by cob(III)alamin reductase (EC 1.6.99.8) and by
cob(II)alamin reductase (EC 1.6.99.9) (36) (Fig.
2). The product of cob(II)alamin reductase, a Co(I) corrinoid, is the substrate for the
ATP:co(I)rrinoid adenosyltransferase (CobA) (EC 2.5.1.17) enzyme
that generates the C-Co bond. This bond is very labile and needs to be
reformed to maintain activity. Hence, this branch of the Ado-Cbl
biosynthetic pathway is essential for coenzyme recycling.
0021-9193/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Reduction of Cob(III)alamin to Cob(II)alamin in
Salmonella enterica Serovar Typhimurium LT2
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (20K):
[in a new window]
FIG. 1.
Structure of Ado-Cbl. In S. enterica the
lower ligand base has been identified to be 5,6-dimethylbenzimidazole
(16).
![]()
View larger version (6K):
[in a new window]
FIG. 2.
Proposed corrinoid adenosylation pathway in S. enterica serovar Typhimurium LT2. Ado, 5'-deoxyadenosine;
e
, electron; flavin(red), reduced forms of
flavin nucleotides; PPPi, tripolyphosphate (postulated to
be the by-product of the CobA reaction in S. enterica
(M. V. Fonseca and J. C. Escalante-Semerana, unpublished
results).
In Salmonella enterica serovar Typhimurium LT2, the CobA enzyme responsible for the last step of the pathway has been isolated and partially characterized (30, 31). Although enzymic activities that can generate reduced corrinoids have been reported and in some cases isolated, the genes encoding the enzymes responsible for the reductive steps of the pathway have not been identified in any organism (2, 15, 36).
Reduction of cob(III)alamin by crude cell-free extracts of Clostridium tetanomorphum and Propionibacterium freundenreichii showed an absolute requirement for added flavin cofactors (3, 36). In these bacteria and in Pseudomonas denitrificans, NADH was the preferred source of electrons for the reaction (2). A system that included thiol compounds, a diaphorase enzyme, NADH, and flavin adenine dinucleotide (FAD) was used to reduce Cbl in P. freundenreichii (3, 15). Interestingly, this complex-reducing system was replaced by FADH2 when purified preparations of the adenosyltransferase from this organism were used. The cob(II)yrinic acid a,c-diamide reductase enzyme of P. denitrificans was isolated and shown to require the addition of flavin cofactors for activity (2). The purified enzyme was shown to reduce complete and incomplete Co(II) corrinoids. Here again, the gene encoding this activity was not identified.
Extensive efforts to isolate mutants of S. enterica serovar Typhimurium LT2 defective in corrinoid reduction and adenosylation have failed to identify genetic loci other than cobA (9; M. V. Fonseca and J. C. Escalante-Semerena, unpublished results). Hence, we took a reverse genetics approach to the isolation of the Cbl reductase enzymes with the purpose of identifying the genes encoding these activities in this bacterium. In this paper, we show that homogeneous NAD(P)H:flavin oxidoreductase (Fre) (EC 1.6.8.1) enzyme drives the reduction of cob(III)alamin and cob(II)alamin by maintaining a pool of dihydroflavins (FMNH2, FADH2), not by directly using cob(III)alamin as the substrate. On the basis of this finding, we propose that S. enterica serovar Typhimurium LT2 may not have or need a cob(III)alamin reductase enzyme. We also show that reduction of cob(II)alamin to cob(I)alamin is detectable in vitro when FMNH2 is present in the reaction mixture. However, the amount of product formed under these conditions was insufficient for CobA enzyme function.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
In vitro activity assays. (i) Reduction of cob(III)alamin to
cob(II)alamin.
The reaction mixture contained:
N-(2-hydroxyethyl)piperazine-N'-(3-propanesulfonic
acid) (HEPPS) buffer (pH 8.0, 0.2 µmol), flavin mononucleotide (FMN)
(0.05 µmol), NADH (0.5 µmol), and cob(III)alamin (0.06 µmol). The
final volume of the reaction mixture was 0.9 ml. Additional components
of the reaction mixture were added using a Hamilton syringe (Hamilton
Co., Reno, Nev.) previously flushed with anoxic water. The reaction
mixture was incubated at 37°C for 2 min, the reaction was initiated
by the addition of enzyme, and incubation was allowed to proceed for 30 min at 37°C under dim light. Cob(III)alamin reductase activity was
determined by measuring the decrease in absorbance at 525 nm as a
function of time, using the difference in the molar extinction
coefficient (
) between HOCbl and cob(II)alamin at that wavelength
(
525 = 4.9 M
1 cm
1)
(34). A unit of activity was defined as the amount of enzyme required to generate 1 nmol of cob(II)alamin per min.
(ii) Reduction of cob(II)alamin to cob(I)alamin. The assay used to detect enzyme-dependent reduction of cob(II)alamin to cob(I)alamin was a modification of the method reported for the isolation of the cob(II)yrinic a,c-diamide reductase enzyme of P. denitrificans. This assay relied on the alkylation of the cob(I)alamin nucleophile (2). The reaction mixture contained the same buffer used to assay the reduction of cob(III)alamin to cob(II)alamin, with the FMN and NADH concentrations as described above. Iodoacetate (IA), (0.4 µmol) was added as a chemical trap for cob(I)alamin, and cob(II)alamin (0.06 µmol) substituted for cob(III)alamin as the substrate. Cob(II)alamin was generated by anoxic photolysis of methylcobalamin (CH3Cbl) (38). Briefly, a solution of CH3Cbl in the reaction buffer was degassed with oxygen-free N2, added to a methacrylate cuvette (Fisher, Itasca, Ill.) fitted with a red-butyl stopper, and flushed with oxygen-free N2 for 10 min. Photolysis of CH3Cbl was achieved by irradiating the sample for 5 min with a 150-W lamp placed ~20 cm away from the cuvette. Conversion of cob(II)alamin to carboxymethyl (CMCbl) was monitored spectrophotometrically by the increase in absorbance at 525 nm as a function of time. This assay was used to monitor the purification of cob(II)alamin reductase activity.
(iii) Corrinoid adenosylation. CobA assays were performed as described previously (31). To determine if S. enterica serovar Typhimurium LT2 cell-free extracts or the Fre protein had cob(II)alamin reductase activity, the corrinoid adenosylation assay was modified by substituting cell-free extracts or Fre, NADH, and FMN for potassium borohydride. A unit of CobA activity was defined as the amount of enzyme that generated 1 nmol of Ado-Cbl per min. Control experiments for the activity of CobA were performed with potassium borohydride as described previously (31).
(iv) Flavin reductase assays.
Flavin reductase activity was
assayed by monitoring oxidation of NADH. Activity was assessed
spectrophotometrically by the decrease in absorbance at 450 nm, as a
function of time. One unit of activity was defined as the amount of
enzyme required to reduce 1 nmol of FMN (
450 = 12,200 M
1 cm
1) (8) per min. The
assays contained FMN or FAD (0.05 µmol), NADH (0.5 µmol), and HEPPS
buffer (pH 8.0, 0.18 mmol) in a final volume of 0.9 ml. Assays were
performed under anoxic conditions to mimic conditions used in the
cob(II)alamin reduction assays (see above).
(v) Photoreduction of FMN and chemical reduction of cob(III)alamin. FMNH2 was generated by photoreduction of coenzyme F420 in the presence of potassium oxalate as a source of reducing equivalents (14, 21). Pyrex tubes (13 by 100 mm) were fitted with a red butyl stopper and degassed with oxygen-free N2 for 30 min. Three milliliters of an anoxic solution of 15 mM potassium oxalate in 0.2 M HEPPS buffer (pH 8.0) was anoxically transferred to the tube with a syringe previously flushed with anoxic buffer. This was followed by the addition of coenzyme F420 (0.005 µmol) and FMN (0.05 µmol). The solution was illuminated with a tungsten/halogen lamp for approximately 10 min. The headspace of the tube was constantly exchanged with oxygen-free N2 during the procedure. Spectra of the solution were recorded when bleaching of the flavin solution was observed. HOCbl (0.05 µmol) was anoxically added to the tube, and reduction of cob(III)alamin to cob(II)alamin was verified spectrophotometrically. After reduction of cob(III)alamin was deemed complete, IA (0.6 µmol) was added and alkylation of cob(I)alamin was monitored as described above.
Protein purification. (i) Purification of the cob(II)alamin reduction activity. (a) Mass culturing of S. enterica serovar Typhimurium LT2. Cells of strain TR6583 (metE205 ara-9 cob+) were grown aerobically in Vogel-Bonner minimal medium (35) with the following additions: glucose (35 mM), cobinamide dicyanide (CN)2Cbi (20 nM), and 1,2-propanediol (12 mM). The latter was used to induce expression of the cob/pdu regulon under aerobic growth conditions (25). Cell mass was concentrated using a tangential flow cell concentrated using a tangential flow cell concentrator (Millipore, Bedford, Mass.), and cells were harvested by centrifugation at 10,000 × g for 10 min. Cell pellets (60 g [wet wt]) were resuspended in 130 ml of buffer A (50 mM Tris-Cl buffer [pH 8.0] at 4°C, 250 µM dithiothreitol) containing 16 µg of the protease inhibitor phenylmethylsulfonyl fluoride per ml.
(b) Generation of cell-free extracts. Cell-free extracts were generated by passing the cell suspension three times through a French pressure cell at 1.4 × 108 kPa. The cell debris was removed by centrifugation at 40,000 × g for 2 h at 4°C.
(c) AS precipitation. Precipitation of proteins with ammonium sulfate (AS) was performed at 4°C using finely ground Ultrapure AS (ICN Biochemicals, Aurora, Ohio). Protein pellets were obtained by centrifugation at 10,000 × g for 10 min at 4°C and resuspended in buffer A. Samples were desalted by dialysis at 4°C for use in subsequent steps. Cob(II)alamin reductase activity precipitated out of solution at between 30 and 45% saturation with AS.
(d) Anion-exchange chromatography. The sample was loaded onto a DEAE-cellulose (Sigma) column (1.5 by 20 cm, 35-ml bed volume) equilibrated with buffer A. The column was developed at a flow rate of 35 ml per h. After the sample was loaded, the column was washed with 53 ml of buffer A and proteins bound to the resin were eluted with a 140-ml linear gradient of NaCl (0 to 0.5 M) in buffer A. Gradient elution was followed by a 53-ml wash with 1 M NaCl in buffer A.
(e) Affinity chromatography. Fractions containing cob(II)alamin reductase activity from the anion-exchange chromatography step were pooled, concentrated using a Centriprep-10 concentrator (Amicon, Beverly, Mass.), and dialyzed against buffer A using a Microdialyzer (Pierce, Rockford, Ill.). The dialyzed sample was loaded onto an FMN-agarose (Sigma) column (0.8 by 4 cm, 2-ml bed volume). The column was washed with 3.0 ml of buffer A, followed by the stepwise elution of bound proteins with 20 µM, 50 µM, and 1 mM FMN in buffer A. Fractions were analyzed by alkylation assays and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Fractions containing a single active protein, as judged by Coomassie blue staining, were pooled together, concentrated using a Centricon-10 microconcentrator (Amicon), and dialyzed against buffer A using a Microdialyzer (Pierce).
(ii) Purification of the CobA enzyme. Purification of the CobA enzyme was performed as described previously, without modifications (31).
Protein techniques. Protein concentration was determined by the method of Kunitz (17). Protein samples were analyzed by SDS-PAGE (18) and stained with Coomassie blue (26). The N-terminal sequence of purified protein samples was performed at the Protein/Nucleic Acid Shared Facility at the Medical College of Wisconsin (Milwaukee, Wis.) as described previously (33).
Genetic techniques. Transductional crosses. Transductional crosses were performed using mutant P22 phage HT105/1 int-201 (27, 28) as described previously (4, 7).
Construction of an S. enterica fre mutant. The fre::kan+ insertion in Escherichia coli strain LS1300 (a gift from C. DiRusso) was moved into the S. enterica chromosome as described previously (13).
Recombinant DNA techniques. (i) General. All plasmid DNA isolations were performed using a QIAprep Spin Plasmid kit (Qiagen, Chatsworth, Calif.). Restriction enzymes and T4 DNA ligase were purchased from Promega (Madison, Wis.) and used according to the manufacturer's instructions. Vent exo mutant DNA polymerase was purchased from New England Biolabs (Beverly, Mass.). Purification of DNA fragments was performed using a QIAquick gel extraction kit. Pfu Turbo DNA polymerase was purchased from Stratagene (San Diego, Calif.). All primers used in this study were synthesized by Integrated DNA Technologies (Coralville, Iowa). DNA sequencing of PCR products and plasmids was performed at the Nucleic Acid and Protein Facility at the University of Wisconsin-Madison Biotechnology Center. PCR conditions and sequencing protocols used have been described elsewhere (32).
(ii) Cloning of the E. coli fre gene.
The
E. coli fre gene was amplified from plasmid pCD140 using the
primers FREPRIMER1 (5'-TTCAAAAATGGGGCTGGATG-3') and
(
)STRAND FRE (5'-CCTACGGTCGGACTATTTG-3'). The
amplification profile was: 94°C for 5 min; 30 cycles of 94°C for 2 min, 45°C for 2 min, and 72°C for 1 min; 72°C for 10 min; and
4°C for 12 h. The amplified fragment was purified, cut with
ClaI and BglII, and ligated into pSU21
(20) cut with ClaI and BamHI enzymes.
The resulting plasmid was referred to as pFRE1.
(iii) Site-directed mutagenesis.
Site-directed mutagenesis
of the fre gene using the three-primer method was performed
as described previously (22). An oligonucleotide with the
sequence 5'-CGACAGAGAAAGCATATGACAAC-3' was used to generate an NdeI site immediately 5' of the fre coding
sequence using plasmid pFRE1 DNA as the template. The
40 and reverse
primers for M13mp19 were used as outer primers in the reaction. The PCR
product was purified, cut with HindIII and
XhoI, and ligated to plasmid pSU19 (20) cut with
the same enzymes. The resulting plasmid was referred to as pFRE2.
(iv) Overproduction of His-tagged Fre enzyme.
Plasmid pFRE2
was cut with NdeI and XhoI, and the fragment
containing fre was purified and ligated to the
overexpression vector pET-15b cut with the same enzymes. The resulting
plasmid was referred to as pFRE3. In this plasmid, expression of
fre results in a Fre protein carrying an N-terminal
histidine tag (His6Fre). His6Fre enzyme was
overproduced from a 500-ml culture of strain JE4639 on Luria-Bertani
broth containing 100 µg of ampicillin per ml. Cells were grown at
37°C with shaking to an A650 of ~0.9.
Isopropyl-1-thio-
-D-galactoside (IPTG) was added to a
final concentration of 400 µM, and incubation was continued for
2 h. After incubation, cells were pelleted by centrifugation at
10,000 × g for 10 min.
(v) Purification of His6Fre protein. Cell pellets were resuspended in 6 ml of binding buffer (5 mM imidazole in 20 mM Tris-Cl buffer [pH 7.9] containing 0.5 M NaCl). The cell suspension was broken by sonication using a 550 Sonic Dismembrator (Fisher) for 10 min (setting of 3, 50% duty). Cell-free extracts were generated by centrifugation at 40,000 × g for 2 h. His6Fre protein was purified from the cell-free extracts by nickel affinity chromatography on a His-bind resin (Novagen, Madison, Wis.) according to the manufacturer's instructions. After the column (1 by 10 cm, 3-ml bed volume) was loaded with cell-free extract, it was washed with 30 ml of binding buffer followed by 18 ml of the same buffer containing 0.06 M imidazole. Proteins bound to the resin were eluted with buffer containing 0.4 M imidazole. Fractions containing homogeneous His6Fre were pooled, dialyzed against 50 mM Tris-Cl (pH 8.0) at 4°C containing 1 mM EDTA, and concentrated using a Centricon microconcentrator (Amicon).
| |
RESULTS |
|---|
|
|
|---|
Isolation of cob(II)alamin reductase activity from cell-free
extracts of S. enterica serovar Typhimurium LT2.
Initial approaches aimed at identifying the cob(II)alamin reductase
enzyme of S. enterica demanded the involvement of the CobA
enzyme under two different assay conditions. First, corrinoid adenosylation was assayed in a reaction mixture that contained cell-free extracts of the wild-type strain (i.e., the extracts contained chromosomal levels of the CobA enzyme), and
cob(III)alamin or cob(II)alamin as the substrate. The second set of
conditions were as described above, except that homogeneous CobA enzyme
was added to the reaction mixture, with the cob(II)alamin reductase activity expected to be provided by cell-free extracts of the wild-type
strain. Neither condition led to the synthesis of cob(I)alamin, the
substrate for the adenosyltransferase enzyme (data not shown). To
increase the sensitivity of the assay, the cob(I)alamin alkylation assay was used to detect cob(II)alamin reductase activity. Using this
assay, a cob(II)alamin reductase activity dependent on FMN and NADH was
detected in cell-free extracts of S. enterica. A protein
with this activity was purified to homogeneity from cell extracts using
conventional liquid chromatography procedures. The anion-exchange step
proved very effective in separating a large number of contaminating
proteins away from the cob(II)alamin reductase activity (data not
shown). A small amount of enzyme (~250 µg) was isolated from
60 g of cells (wet paste), indicating that this enzyme was not a
very abundant protein. After the affinity chromatography step, some
fractions containing this activity had a single protein of a molecular
mass of approximately 29 kDa (Fig. 3).
N-terminal sequence analysis of the first 15 amino acids of the
purified protein yielded the sequence TTLSCKVTSVEAITD, a perfect match
to the E. coli Fre (encoded by the fre gene)
(11, 29). This finding was surprising because this enzyme
was not expected to catalyze the reduction of cob(II)alamin to
cob(I)alamin given the extremely low redox potential of the
cob(II)alamin/cob(I)alamin couple (E0' =
0.61V
[1, 19]). Noteworthy is the fact that this reduction
was monitored using in vitro alkylation assays. Under the conditions of
the assay, reduction of cob(II)alamin was linear with time, but the
rate of alkylation of cob(I)alamin did not change with increasing
concentrations of Fre protein in the assay mixture (data not shown).
These results suggested that the generation of cob(I)alamin was not
enzymic. To test this possibility, FMNH2 was generated
photochemically and was added to alkylation assay mixtures devoid of
Fre protein and NADH. Complete reduction of cob(II)alamin was measured
only when a 2:1 ratio of FMNH2 to cob(III)alamin was
present in the reaction mixture.
|
FMNH2 did not substitute for potassium borohydride in the reaction catalyzed by the CobA enzyme. CobA-dependent corrinoid adenosylation assays were performed to assess whether Fre generated the cob(I)alamin substrate for CobA. No CobA activity was detected under the conditions routinely used to assay this enzyme. Reaction mixtures containing varying amounts of Fre (6 to 12 µg), NADH, and FMN failed to substitute for potassium borohydride in the reduction of cob(II)alamin to cob(I)alamin. Control experiments where cob(I)alamin was generated with potassium borohydride (31) indicated that the CobA enzyme used in these experiments was active.
Fre protein is required for reduction of cob(III)alamin to
cob(II)alamin.
Reduction of cob(III)alamin by homogeneous
His6Fre enzyme (Fig. 4) was
tested in vitro by measuring the rate of reduction of cob(III)alamin to
cob(II)alamin (i) under conditions that assumed cob(III)alamin served
as substrate for Fre and (ii) under conditions where flavin reduction
was allowed to proceed to completion before the addition of
cob(III)alamin to the reaction mixture. Under the conditions where
cob(III)alamin was assumed to serve as substrate for Fre, the rate of
cob(III)alamin reduction correlated well with the rate of flavin
reduction. Under these conditions, cob(III)alamin and FMN reduction was
linear when the amount of Fre in the reaction mixture was between 0.2 and 0.45 µg of protein. Within this range of enzyme, FMN was reduced
at a rate of 2.4 to 7.8 nmol of FMNH2 per min. Within the
same range of Fre concentration, cob(III)alamin was reduced at a rate
of 2.7 to 9.2 nmol per min. In contrast, the rate of reduction of
cob(III)alamin to cob(II)alamin (Fig. 5) was too fast to be measured when
cob(III)alamin was added after FMN or FAD was converted to
FMNH2 or FADH2 (Fig. 5 shows the reaction with
FADH2). These results suggested that reduction of
cob(III)alamin to cob(II)alamin was not enzymic, but chemical.
Thus, it was inferred that Fre was indirectly driving the reduction of
cob(III)alamin to cob(II)alamin via either FMNH2 or
FADH2 and that flavin reduction was the rate-limiting
reaction for cob(III)alamin reduction. When cob(III)alamin was added to
a solution of photochemically reduced FMNH2,
cob(III)alamin reduction was again too fast to be measured, confirming that this reaction was dependent on FMNH2 and
that cob(III)alamin was not used as a substrate by Fre.
|
|
Phenotypes of an S. enterica fre mutant. The phenotypes of an S. enterica fre mutant were assessed by their ability to synthesize methionine aerobically when provided with nonadenosylated cobinamide, or anaerobically, by demanding de novo Cbl synthesis (9). Under aerobic conditions, a cobA mutant (lacks adenosyltransferase activity) cannot synthesize Cbl (and thus is a methionine auxotroph) unless adenosylcobinamide is provided in the medium (9). Anaerobically, a cobA mutant is defective in corrin ring biosynthesis and is corrected by addition of Cbl to the medium (9). If the Fre enzyme were part of the corrinoid adenosylation pathway in this bacterium, a fre mutant would be predicted to have a CobA-like phenotype. The fre mutant did not display a CobA-like phenotype, i.e., it synthesized adenosylcobalamin de novo under anaerobic conditions and from nonadenosylated cobinamide, indicating that alternative means of achieving cob(II)alamin reduction exist in this bacterium.
| |
DISCUSSION |
|---|
|
|
|---|
Fre is not responsible for the reduction of cob(II)alamin to cob(I)alamin. We have demonstrated that Fre can promote the disproportionation reaction of cob(II)alamin to cob(I)alamin (39) by always maintaining FMN in a reduced state. This effect of Fre on cob(II)alamin reduction is indirect, because photochemically reduced FMN substituted for Fre and NADH in this reaction. On the basis of this result, we conclude that reduction of the cob(II)rrinoid via Fre does not require binding of this substrate to the Fre enzyme. Even though dihydroflavins have been alluded to be active in corrinoid reduction (3, 15), to the best of our knowledge, these observations were not published. Identification of bona fide cob(II)alamin reductase (EC 1.6.99.9) enzymes must demand in vitro coupling with the CobA enzyme. The lack of coupling between the Fre and CobA enzymes suggested that the level of cob(I)-alamin generated by FMNH2 oxidation was either below the Km of CobA for this substrate (5.2 µM [31]) or it was reoxidized to cob(II)alamin before binding to CobA. The results of alkylation assays were misleading due to the reactivity of the cob(I)alamin nucleophile and the IA electrophile.
Does S. enterica have cob(III)alamin reductase enzyme activity? Reduction of cob(III)alamin to cob(II)alamin by FMNH2 suggested that flavin reductase enzymes such as Fre drive the reduction of cob(III)alamin to cob(II)alamin by maintaining a pool of dihydrofalvins. The existence of FMNH2 and FADH2 effectively bypasses the need for a specific reductase. Organisms like E. coli (and probably S. enterica) and luminous bacteria have more than one in vitro-detectable flavin reductase enzyme activity (5, 6, 10, 40, 41). Such a redundancy of function makes it likely that cob(II)alamin is the stable, intracellular form of this coenzyme, which would also explain why mutant strains defective in cob(III)alamin reductase function have not been isolated. Alternatively, reduction of cob(III)alamin to cob(I)alamin in S. enterica may be catalyzed by a single enzyme performing two one-electron reductions. In contrast with S. enterica, mammalian cells contain two different forms of cob(III)alamin reductase (24). Surprisingly, in this system, nonenzymatic reduction of cob(III)alamin by reducing substrates or low-molecular-weight factors has not been observed. Cob(III)alamin reductase has also been isolated and characterized in the protozoan Euglena gracilis (37). The E. gracilis and mammalian enzymes do not require FAD or FMN for the reduction of cob(III)alamin. The E. gracilis enzyme contains FAD or FMN as its prosthetic group (37).
Another plausible explanation for the lack of success in isolating Cbl reductase mutants could be that one of the redundant functions is required for de novo synthesis of the corrin ring and another is required for assimilation of exogenous corrinoids. A fre mutant was able to synthesize Ado-Cbl de novo anaerobically, and it assimilated exogenous corrinoids both aerobically and anaerobically, suggesting that Fre was not solely responsible for the reduction of the corrin ring.Why have S. enterica mutants defective in cob(II)alamin reduction not been isolated? Genetic approaches that led to the isolation of CobA mutants did not result in isolation of mutants defective in corrinoid reduction (9). Exhaustive mutant searches in an fre mutant background failed to isolate strains with a CobA-like phenotype (adenosylcobinamide auxotroph) with lesions in genes other than cobA (data not shown). The difficulty in the identification of the gene encoding the cob(II)alamin reductase enzyme would be explained if cob(II)alamin reduction in S. enterica were catalyzed by an essential enzyme, by more than two enzymes (i.e., redundancy), or by an enzyme that may be required for functions other than cob(II)rrinoid reduction.
Database searches for putative cobalamin reductases from known bacterial and archael genome sequences based on proximity to cobalamin biosynthetic genes have not been productive. Because the genes encoding previously isolated cob(II)alamin reductase activities in P. denitrificans, C. tetanomorphum, and P. freundenreichii were not been identified, it is not possible to identify homologous proteins in S. enterica based on sequence homology at this point. Given the extreme reactivity of the co(I)rrinoid nucleophile, it is likely that during the synthesis of adenosylated corrinoids, reduction of co(II)rrinoids occurs on the adenosyltransferase enzyme once it has complexed with its substrate and ATP. Precedent for this idea has been provided through in vitro studies of activation of the cob(II)alamin form of methionine synthase (MetH) in E. coli (1, 23). In vitro, the reduction of cob(II)alamin bound to the methionine synthase MetH enzyme is catalyzed by reduced flavodoxin (FldA) (14, 23). Interactions between the FldA and MetH proteins change the coordination geometry of the cobalt from five-coordinate geometry to four-coordinate geometry due to the dissociation of residue His759 of MetH, which replaces the lower ligand base 5,6-dimethylbenzimidazole when Cbl is bound by the enzyme. The association of FldA and MetH proteins is specific and depends on pH and ionic strength (14). Because the fldA gene is essential (12), the Cob phenotype associated with a lack of this function is unknown. If FldA indeed has a role in corrinoid reduction for adenosylation, this would imply some differences in the in vitro requirements of the previously identified reducing systems in other organisms, since all these systems required the addition of flavins for activity. The possible involvement of FldA in corrinoid reduction and adenosylation in S. enterica is currently under investigation in our laboratory.| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grant GM40313 and by an Aid-to-Education grant from DuPont to J.C.E.-S. M.V.F. is the recipient of MARC predoctoral fellowship GM17528.
We thank C. DiRusso (The Albany Medical College, Albany, N.Y.) for plasmids and strains. We thank H. Beinert (Institute for Enzyme Research, University of Wisconsin-Madison) for assistance in performing the photochemical reduction of FMN. We thank B. Mukhopadhyay and R. S. Wolfe (University of Illinois-Urbana-Champaign) for the gift of coenzyme F420.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Bacteriology, University of Wisconsin-Madison, 1550 Linden Dr., Madison, WI 53706-1567. Phone: (608) 262-7379. Fax: (608) 262-9865. E-mail: jcescala{at}facstaff.wisc.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Banerjee, R. V., S. R. Harder, S. W. Ragsdale, and R. G. Matthews. 1990. Mechanism of reductive activation of cobalamin-dependent methionine synthase: an electron paramagnetic resonance spectroelectrochemical study. Biochemistry 29:1129-1135[CrossRef][Medline]. |
| 2. |
Blanche, F.,
L. Maton,
L. Debussche, and D. Thibaut.
1992.
Purification and characterization of cob(II)yrinic acid a,c-diamide reductase from Pseudomonas denitrificans.
J. Bacteriol.
174:7452-7454 |
| 3. |
Brady, R. O.,
E. G. Castanera, and H. A. Barker.
1962.
The enzymatic synthesis of cobamide coenzymes.
J. Biol. Chem.
237:2325-2332 |
| 4. | Chan, R. K., D. Botstein, T. Watanabe, and Y. Ogata. 1972. Specialized transduction of tetracycline resistance by phage P22 in Salmonella typhimurium. II. Properties of a high transducing lysate. Virology 50:883-898[CrossRef][Medline]. |
| 5. | Covès, J., and M. Fontecave. 1993. Reduction and mobilization of iron by a NAD(P)H:flavin oxidoreductase from Escherichia coli. Eur. J. Biochem. 211:635-641[Medline]. |
| 6. |
Covès, J.,
V. Niviere,
M. Eschenbrenner, and M. Fontecave.
1993.
NADPH-sulfite reductase from Escherichia coli. A flavin reductase participating in the generation of the free radical of ribonucleotide reductase.
J. Biol. Chem.
268:18604-18609 |
| 7. | Davis, R. W., D. Botstein, and J. R. Roth. 1980. A manual for genetic engineering: advanced bacterial genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 8. | Dawson, R. M. C., D. C. Elliott, W. H. Elliott, and K. M. Jones. 1986. Data for biochemical research, 3rd ed. Oxford University Press, Oxford, United Kingdom. |
| 9. |
Escalante-Semerena, J. C.,
S.-J. Suh, and J. R. Roth.
1990.
cobA function is required for both de novo cobalamin biosynthesis and assimilation of exogenous corrinoids in Salmonella typhimurium.
J. Bacteriol.
172:273-280 |
| 10. |
Fieschi, F.,
V. Nivière,
C. Frier,
J.-L. Décount, and M. Fontecave.
1995.
The mechanism and substrate specificity of the NADPH:flavin oxidoreductase from Escherichia coli.
J. Biol. Chem.
270:30392-30400 |
| 11. |
Fontecave, M.,
R. Eliasson, and P. Reichard.
1987.
NAD(P)H:flavin oxidoreductase of Escherichia coli. A ferric iron reductase participating in the generation of the free radical of ribonucleotide reductase.
J. Biol. Chem.
262:12325-12331 |
| 12. |
Gaudu, P., and B. Weiss.
2000.
Flavodoxin mutants of Escherichia coli K-12.
J. Bacteriol.
182:1788-1793 |
| 13. |
Hamilton, C. M.,
M. Aldea,
B. K. Washburn,
P. Babitzke, and S. R. Kushner.
1989.
New method for generating deletions and gene replacements in Escherichia coli.
J. Bacteriol.
171:4617-4622 |
| 14. | Hoover, D. M., J. T. Jarrett, R. H. Sands, W. R. Dunham, M. L. Ludwig, and R. G. Matthews. 1997. Interactions of Escherichia coli cobalamin-dependent methionine synthase and its physiological partner flavodoxin: binding of flavodoxin leads to axial ligand dissociation from the cobalamion cofactor. Biochemistry 36:127-138[CrossRef][Medline]. |
| 15. | Huennekens, F. M., K. S. Vitols, K. Fujii, and D. W. Jacobsen. 1982. Biosynthesis of cobalamin coenzymes, p. 145-168. In D. Dolphin (ed.), B12, vol. 1. John Wiley & Sons, Inc., New York, N.Y. |
| 16. |
Johnson, M. G., and J. C. Escalante-Semerena.
1992.
Identification of 5,6-dimethylbenzimidazole as the Co ligand of the cobamide synthesized by Salmonella typhimurium: nutritional characterization of mutants defective in biosynthesis of the imidazole ring.
J. Biol. Chem.
267:13302-13305 |
| 17. |
Kunitz, M. J.
1952.
Crystalline inorganic pyrophosphatase isolated from baker's yeast.
J. Gen. Physiol.
35:423-450 |
| 18. | Laemmli, U. K. 1970. Cleavage and structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685[CrossRef][Medline]. |
| 19. | Lexa, D., and J.-M. Saveant. 1983. The electrochemistry of vitamin B12. Acc. Chem. Res. 16:235-243[CrossRef]. |
| 20. |
Martínez, E.,
B. Bartolomé, and F. de la Cruz.
1988.
pACY184-derived cloning vectors containing the multiple cloning site and lacZ reporter gene of pUC8/9 and pUC18/19 plasmids.
Gene
68:159-162[CrossRef][Medline].
|
| 21. |
Massey, V., and P. Hemmerich.
1977.
A photochemical procedure for reduction of oxidation-reduction proteins employing deazariboflavin as catalyst.
J. Biol. Chem.
252:5612-5614 |
| 22. | Michael, S. F. 1994. Mutagenesis by incorporation of a phosphorylated oligo during PCR amplification. BioTechniques 16:410-414[Medline]. |
| 23. |
Osborne, C.,
L.-M. Chen, and R. G. Matthews.
1991.
Isolation, cloning, mapping, and nucleotide sequencing of the gene encoding flavodoxin in Escherichia coli.
J. Bacteriol.
173:1729-1737 |
| 24. |
Pezacka, E. H.
1993.
Identification and characterization of two enzymes involved in the intracellular metabolism of cobalamin. Cyanocobalamin -ligand transferase and microsomal cob(III)alamin reductase.
Biochim. Biophys. Acta
1157:167-177[Medline].
|
| 25. |
Rondon, M. R., and J. C. Escalante-Semerena.
1992.
The poc locus is required for 1,2-propanediol-dependent transcription of the cobalamin biosynthetic (cob) and propanediol utilization (pdu) genes of Salmonella typhimurium.
J. Bacteriol.
174:2267-2272 |
| 26. | Sasse, J. 1991. Detection of proteins, p. 10.6.1-10.6.8. In F. A. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 1. Wiley Interscience, New York, N.Y. |
| 27. | Schmieger, H. 1971. A method for detection of phage mutants with altered transduction ability. Mol. Gen. Genet. 100:378-381. |
| 28. | Schmieger, H., and H. Bakhaus. 1973. The origin of DNA in transducing particles of P22 mutants with increased transduction frequencies (HT-mutants). Mol. Gen. Genet. 120:181-190[CrossRef][Medline]. |
| 29. |
Spyrou, G.,
E. Haggård-Ljungquist,
M. Krook,
H. Jörnvall,
E. Nilsson, and P. Reichard.
1991.
Characterization of the flavin reductase gene (fre) of Escherichia coli and construction of a plasmid for overproduction of the enzyme.
J. Bacteriol.
173:3673-3679 |
| 30. | Suh, S.-J. 1994. Ph.D. dissertation. University of Wisconsin, Madison. |
| 31. |
Suh, S.-J., and J. C. Escalante-Semerena.
1995.
Purification and initial characterization of the ATP:corrinoid adenosyltransferase encoded by the cobA gene of Salmonella typhimurium.
J. Bacteriol.
177:921-925 |
| 32. |
Thomas, M. G.,
G. A. O'Toole, and J. C. Escalante-Semerena.
1999.
Molecular characterization of eutF mutants of Salmonella typhimurium LT2 identifies eutF lesions as partial-loss-of-function tonB alleles.
J. Bacteriol.
181:368-374 |
| 33. |
Trzebiatowski, J. R., and J. C. Escalante-Semerena.
1997.
Purification and characterization of CobT, the nicotinate mononucleotide:5,6-dimethylbenzimidazole phosphoribosyltransferase enzyme from Salmonella typhimurium LT2.
J. Biol. Chem.
272:17662-17667 |
| 34. |
Vitols, E.,
G. A. Walker, and F. M. Huennekens.
1966.
Enzymatic conversion of vitamin B12s to a cobamide coenzyme, -(5,6-dimethylbenzimidazolyl)deoxy-adenosylcobamide (adenosyl-B12).
J. Biol. Chem.
241:1455-1461 |
| 35. |
Vogel, H. J., and D. M. Bonner.
1956.
Acetylornithase of Escherichia coli: partial purification, and some properties.
J. Biol. Chem.
218:97-106 |
| 36. | Walker, G. A., S. Murphy, and F. M. Huennekens. 1969. Enzymatic conversion of vitamin B12a to adenosyl-B12: evidence for the existence of two separate reducing systems. Arch. Biochem. Biophys. 134:95-102[CrossRef][Medline]. |
| 37. |
Watanabe, F.,
Y. Oki,
Y. Nakano, and S. Kitaoka.
1987.
Purification and characterization of aquacobalamin reductase (NADPH) from Euglena gracilis.
J. Biol. Chem.
262:11514-11518 |
| 38. | Yamada, R., S. Shimizu, and S. Fukui. 1971. Preparation of solid vitamin B12r by anaerobic photolysis of methylcobalamin. Methods Enzymol. 18C:52-54. |
| 39. | Yamada, R.-H., S. Schimizu, and S. Fukui. 1968. Disproportionation of vitamin B12r under various mild conditions. Biochemistry 7:1713-1719[CrossRef][Medline]. |
| 40. |
Zenno, S.,
T. Kobori,
M. Tanokura, and K. Saigo.
1998.
Conversion of NfsA, the major Escherichia coli nitroreductase, to a flavin reductase with an activity similar to that of Frp, a flavin reductase in Vibrio harveyi, by a single amino acid substitution.
J. Bacteriol.
180:422-425 |
| 41. |
Zenno, S.,
K. Saigo,
H. Kanoh, and S. Inouye.
1994.
Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744.
J. Bacteriol.
176:3536-3543 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»